首页/数据集/Diagnostic phenotypes of anti-SARS-CoV-2 immunoassay results from 8999 samples tested.

Diagnostic phenotypes of anti-SARS-CoV-2 immunoassay results from 8999 samples tested.

Figshare2021-09-23 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Diagnostic_phenotypes_of_anti-SARS-CoV-2_immunoassay_results_from_8999_samples_tested_/16672551 数据链接链接失效反馈

官方服务：

资源简介：

Diagnostic phenotypes of anti-SARS-CoV-2 immunoassay results from 8999 samples tested.

应用场景：

创建时间：

2021-09-23

COVID-19血液学分析

免疫效果评估

COVIDIAGNOSTIX - Health Technology Assessment in Covid serological diagnostics. SARS-COV-2 serologcal results, obtained in serial evaluations at 0,1,3,6 months from the first dose of anti-Sars-CoV-2

NIAID Data Ecosystem80

Haematological and serum biochemistry parameters in COVID-19 patients with mild and severe disease.

COVID-19血液学分析

疾病严重程度评估

Haematological and serum biochemistry parameters in COVID-19 patients with mild and severe disease.

NIAID Data Ecosystem40

Table_4_Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Serological Diagnostic Tests and Antibody Kinetics in Coronavirus Disease 2019 Patients.DOCX

COVID-19血液学分析

动力学分析

Serological testing is recommended to support the detection of undiagnosed coronavirus disease 2019 (COVID-19) cases. However, the performance of serological assays has not been sufficiently evaluated

NIAID Data Ecosystem20

Data_Sheet_1_High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study.docx

COVID-19血液学分析

化学发光免疫分析

Objectives: COVID-19 emerged and rapidly spread throughout the world. Testing strategies focussing on patients with COVID-19 require assays that are high-throughput, low-risk of infection, and with sm

NIAID Data Ecosystem50

DataSheet_1_Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2.pdf

抗体检测技术开发

COVID-19血液学分析

Low-volume antibody assays can be used to track SARS-CoV-2 infection rates in settings where active testing for virus is limited and remote sampling is optimal. We developed 12 ELISAs detecting total

NIAID Data Ecosystem30

Diagnostic phenotypes of anti-SARS-CoV-2 immunoassay results from 8999 samples tested.

资源简介：

相关数据集